Deep TMS is NOT Contraindicated in Recurrent Headaches
Deep transcranial magnetic stimulation (deep TMS) is not contraindicated in patients with recurrent headaches; in fact, emerging evidence suggests it may be beneficial for treatment-resistant chronic migraine. The primary safety concern with TMS is headache as a common side effect, not recurrent headaches as a contraindication.
Evidence for Safety and Use in Headache Disorders
Deep TMS for Chronic Migraine Treatment
A preliminary study specifically evaluated high-frequency deep TMS as add-on therapy for treatment-resistant chronic migraine 1. The treatment protocol involved:
- 10 Hz stimulation to bilateral dorsolateral prefrontal cortex (DLPFC)
- 600 pulses in 10 trains per session
- 12 sessions over one month
The study demonstrated that deep TMS was well-tolerated and significantly reduced pain intensity, attack frequency, analgesic overuse, and depressive symptoms compared to standard pharmacological treatment alone 1.
Broader TMS Evidence in Headache
A systematic review of TMS and tDCS for headache treatment found that repetitive TMS (rTMS) shows the most promise, with moderate evidence for reductions in headache frequency, duration, intensity, and medication use 2. The International Neuromodulation Society expert consensus panel rated the evidence level as moderate for migraine prevention and recommended TMS as a viable treatment option 3.
Safety Profile and Common Side Effects
Headache as a Side Effect, Not a Contraindication
The key distinction is that headache is a common treatment-emergent side effect of TMS (not a contraindication). A retrospective study of 938 patients receiving rTMS found 4:
- Treatment-emergent headaches occurred more frequently in younger patients and women
- Headache occurrence was associated with patient characteristics (age, gender, baseline depression severity) rather than stimulation parameters
- Headaches did not affect clinical response rates and actually improved treatment retention when properly managed
Established Contraindications
The actual contraindications to TMS are 5:
- Metal or electronic implants in the head/neck (pacemakers, cochlear implants)
- History of seizures or epilepsy
- Pregnancy (relative contraindication requiring special consideration)
- Certain medications that lower seizure threshold
Recurrent headaches are notably absent from this list.
Clinical Recommendations
When to Consider Deep TMS for Headache Patients
Deep TMS should be considered for patients with:
- Treatment-resistant chronic migraine not responding to standard pharmacological therapy 1
- Medication overuse headache requiring non-pharmacological intervention
- Comorbid depression and migraine (dual benefit) 3
Managing Treatment-Emergent Headaches
If headaches occur during TMS treatment 4:
- Provide individualized patient support during early treatment phases
- Reassure patients that headaches are common, mild, and do not predict poor outcomes
- Consider analgesics as needed
- Continue treatment as headaches typically do not affect efficacy
Important Caveats
- The evidence for deep TMS in migraine is still preliminary with small sample sizes 1, 2
- Most robust evidence exists for repetitive TMS rather than deep TMS specifically
- Standardized protocols are still being developed
- Cost-effectiveness and long-term outcomes require further study 3
In summary, not only is deep TMS not contraindicated in recurrent headaches, but it represents a promising non-pharmacological treatment option for patients with treatment-resistant chronic migraine, particularly when combined with standard therapy.